Lupin Limited Total Assets

Latest as of March 2026: Rs383.65 Billion INR ≈ $4.15 Billion USD

Lupin Limited total assets. Based on the latest financial reports, Lupin Limited (LUPIN) holds total assets worth Rs383.65 Billion INR (≈ $4.15 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see LUPIN market cap for the company's overall valuation and market capitalisation.

Total Assets of Lupin Limited (2004–2026)

Total assets of Lupin Limited from 2004 to 2026. This chart illustrates how Lupin Limited's total assets have evolved over time, based on quarterly financial data. See LUPIN stock price for real-time trading data and today's change.

Lupin Limited - Asset Composition Analysis

Lupin Limited Total Assets Breakdown (March 2026)

Lupin Limited total assets breakdown as of March 2026. Lupin Limited's total assets of Rs383.65 Billion consist of 62.6% current assets and 37.4% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	14.7%
Accounts Receivable	Rs66.07 Billion	17.2%
Inventory	Rs60.83 Billion	15.9%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs32.07 Billion	8.4%
Goodwill	Rs26.59 Billion	6.9%

Asset Composition Trend (2004–2026)

This chart illustrates how Lupin Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Lupin Limited (LUPIN) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Lupin Limited's current assets represent 62.6% of total assets in 2026, an increase from 56.0% in 2004.
Cash Position: Cash and equivalents constituted 14.7% of total assets in 2026, up from 2.5% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 0.0% in 2004.
Asset Diversification: The largest asset category is accounts receivable at 17.2% of total assets.

Lupin Limited Competitors by Total Assets

Key competitors of Lupin Limited based on total assets are shown below.

Company	Country	Total Assets
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Galderma Group N SW:GALD	Switzerland	CHF12.88 Billion
Enzymatica publ AB ST:ENZY	Sweden	Skr149.24 Million
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥13.98 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Walvax BioTech SHE:300142	China	CN¥10.50 Billion

Lupin Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.90	1.87	1.66
Quick Ratio	1.42	1.26	1.17
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs113.76 Billion	Rs78.37 Billion	Rs55.50 Billion

Lupin Limited - Advanced Valuation Insights

This section examines the relationship between Lupin Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	4.27
Latest Market Cap to Assets Ratio	0.03
Asset Growth Rate (YoY)	31.4%
Total Assets	Rs383.65 Billion
Market Capitalization	$9.94 Billion USD

Valuation Analysis

Below Book Valuation: The market values Lupin Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Lupin Limited's assets grew by 31.4% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Lupin Limited (2004–2026)

The table below shows the annual total assets of Lupin Limited from 2004 to 2026.

Year	Total Assets	Change
2026-03-31	Rs383.65 Billion ≈ $4.15 Billion	+31.36%
2025-03-31	Rs292.05 Billion ≈ $3.16 Billion	+21.70%
2024-03-31	Rs239.97 Billion ≈ $2.60 Billion	+4.54%
2023-03-31	Rs229.56 Billion ≈ $2.48 Billion	+5.20%
2022-03-31	Rs218.21 Billion ≈ $2.36 Billion	-7.58%
2021-03-31	Rs236.10 Billion ≈ $2.55 Billion	-5.50%
2020-03-31	Rs249.84 Billion ≈ $2.70 Billion	-10.61%
2019-03-31	Rs279.49 Billion ≈ $3.02 Billion	+6.25%
2018-03-31	Rs263.05 Billion ≈ $2.84 Billion	-1.13%
2017-03-31	Rs266.07 Billion ≈ $2.88 Billion	+17.60%
2016-03-31	Rs226.25 Billion ≈ $2.45 Billion	+72.21%
2015-03-31	Rs131.38 Billion ≈ $1.42 Billion	+28.73%
2014-03-31	Rs102.06 Billion ≈ $1.10 Billion	+14.50%
2013-03-31	Rs89.14 Billion ≈ $964.00 Million	+11.67%
2012-03-31	Rs79.82 Billion ≈ $863.25 Million	+30.34%
2011-03-31	Rs61.24 Billion ≈ $662.33 Million	+20.43%
2010-03-31	Rs50.85 Billion ≈ $549.97 Million	+23.01%
2009-03-31	Rs41.34 Billion ≈ $447.09 Million	+22.90%
2008-03-31	Rs33.64 Billion ≈ $363.78 Million	+48.64%
2007-03-31	Rs22.63 Billion ≈ $244.73 Million	+12.71%
2006-03-31	Rs20.08 Billion ≈ $217.13 Million	+48.25%
2005-03-31	Rs13.54 Billion ≈ $146.46 Million	+10.10%
2004-03-31	Rs12.30 Billion ≈ $133.02 Million	--

About Lupin Limited

NSE:LUPIN India Drug Manufacturers - Specialty & Generic

Market Cap

$9.94 Billion

Rs919.56 Billion INR

Market Cap Rank

#2175 Global

#90 in India

Share Price

Rs2011.00

Change (1 day)

+1.06%

52-Week Range

Rs1922.00 - Rs2514.80

All Time High

Rs2514.80